Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Capital Leases (2022 - 2025)

Rockwell Medical (RMTI) has disclosed Capital Leases for 7 consecutive years, with $423000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Capital Leases fell 61.01% year-over-year to $423000.0, compared with a TTM value of $423000.0 through Sep 2025, down 61.01%, and an annual FY2024 reading of $931000.0, down 39.15% over the prior year.
  • Capital Leases was $423000.0 for Q3 2025 at Rockwell Medical, down from $614000.0 in the prior quarter.
  • Across five years, Capital Leases topped out at $2.1 million in Q4 2022 and bottomed at $423000.0 in Q3 2025.
  • Average Capital Leases over 4 years is $1.3 million, with a median of $1.3 million recorded in 2024.
  • The sharpest move saw Capital Leases dropped 26.72% in 2023, then crashed 61.01% in 2025.
  • Year by year, Capital Leases stood at $2.1 million in 2022, then dropped by 26.72% to $1.5 million in 2023, then tumbled by 39.15% to $931000.0 in 2024, then plummeted by 54.56% to $423000.0 in 2025.
  • Business Quant data shows Capital Leases for RMTI at $423000.0 in Q3 2025, $614000.0 in Q2 2025, and $774000.0 in Q1 2025.